STOCK TITAN

AmpliTech Group (AMPG) lifts margins, raises cash and okays $10M buyback

(Moderate)
(Neutral)
Form Type
10-Q

Rhea-AI Filing Summary

AmpliTech Group, Inc. reported Q2 2026 revenue of $8.1 million, down 26.81% from Q2 2025, and six‑month 2026 revenue of $13.4 million, down 8.24%. Despite lower sales, gross profit improved to $2.3 million in Q2 and $4.8 million for six months, with gross margin rising to 27.93% in Q2 and 35.92% year‑to‑date, driven by a more favorable product mix and the absence of lower‑margin acquired 5G product sales.

Operating expenses rose sharply as the company invested in 5G development, marketing, trade shows, consulting and stock‑based compensation, lifting SG&A to $7.8 million and R&D to $1.9 million for the first half. As a result, the net loss widened to $3.1 million in Q2 and $4.6 million for six months, and operating activities used $8.7 million of cash.

Liquidity strengthened through a rights offering and a registered direct offering that together added over $16.4 million of equity capital in the first half, ending June 30 with $8.9 million in cash and cash equivalents, $22.9 million of working capital, and $46.8 million of stockholders’ equity. Subsequent to quarter‑end, the company raised approximately $21.9 million from the exercise of Series A Rights and announced a $10 million stock repurchase program. Management continues to report material weaknesses in internal control over financial reporting and is pursuing its remediation plan.

Positive

  • Gross margin expansion: Six‑month 2026 gross profit rose to $4,820,878 from $2,050,749, with gross margin improving to 35.92% from 14.02%, reflecting a more favorable product mix.
  • Stronger equity and liquidity: As of June 30, 2026, cash and cash equivalents were $8,892,838, working capital was $22,932,180, and stockholders’ equity was $46,753,882, supported by recent equity raises.
  • Additional capital post‑quarter: Exercise of 4,384,163 Series A Rights on July 22, 2026 generated approximately $21,920,815 in gross proceeds and $20,121,994 in net proceeds, further bolstering the balance sheet.
  • Shareholder return authorization: On July 7, 2026, the board approved a $10 million stock repurchase program over 24 months, providing flexibility to return capital to shareholders.
  • Reduced 5G acquisition cost: Amendment No. 2 to the Titan APA decreased the aggregate purchase price from $8,000,000 to $7,000,000, lowering the remaining consideration for the 5G ORAN radio assets.

Negative

  • Revenue decline: Q2 2026 revenue fell to $8,070,379, a 26.81% decrease year over year, and six‑month revenue declined 8.24% to $13,419,825, reflecting weaker 5G product sales.
  • Widening losses: Net loss increased to $3,088,512 in Q2 2026 from $1,771,625, and to $4,610,219 for six months from $3,612,146, driven by higher SG&A and R&D spending.
  • Heavy cash burn: Net cash used in operating activities was $8,678,386 for the six months ended June 30, 2026, more than double the $4,260,237 used in the prior‑year period.
  • Rising operating expenses: Six‑month 2026 selling, general and administrative expenses rose to $7,758,455, up 73.67%, and R&D increased to $1,877,451, up 34.25%, pressuring profitability.
  • Ongoing control weaknesses: Management concluded that disclosure controls and internal control over financial reporting were not effective as of June 30, 2026 due to continuing material weaknesses.

Filing Explained

Future equity issuance remains possible through 700,002 service shares, Series B Rights, and a conditional 1 million dollar Titan stock payment.

Form 10-Q is an unaudited quarterly report; this filing reports that the Series A closing was completed on July 22, 2026, while Series B Rights remain outstanding through November 20, 2026. More materially for existing common holders, $700,002 shares remain scheduled for monthly issuance from October, and the amended Titan purchase leaves $1 million payable in restricted stock if specified transfer and production-readiness conditions are met.

As of June 30, 2026, the company reported 11,416,410 potential common shares excluded from diluted loss per share, consisting of options, warrants, Series A and Series B Rights, and unvested equity awards. These are not all issued shares: the filing distinguishes outstanding rights, options, and awards from shares already issued, while additional shares would reduce existing holders’ percentage ownership if issued.

Separately, the company terminated its Equity Distribution Agreement with Maxim on July 7, 2026, ending that disclosed distribution arrangement. The remaining Series B Rights will be resolved at their November 20, 2026 expiration, while the Titan stock obligation depends on transfer of the completed design package and acknowledgment that its documentation is suitable for full production.

Q2 2026 Revenue $8,070,379 Three months ended June 30, 2026 revenue
Q2 2026 Net Loss $(3,088,512) Net loss for the three months ended June 30, 2026
Six-month 2026 Revenue $13,419,825 Revenue for the six months ended June 30, 2026
Net Cash Used in Operating Activities $(8,678,386) Net cash used in operating activities for six months ended June 30, 2026
Cash and cash equivalents $8,892,838 Balance of cash and cash equivalents at June 30, 2026
Working capital $22,932,180 Working capital position at June 30, 2026
Net proceeds from Series A Rights Closing $20,121,994 Net proceeds from exercise of 4,384,163 Series A Rights on July 22, 2026
Authorized stock repurchase program $10,000,000 Maximum amount authorized for common stock repurchases over 24 months from July 7, 2026
rights offering financial
"On January 14, 2026, the Company closed on a rights offering of transferable Unit Subscription Rights"
A rights offering is a way for a company to raise additional money by giving existing shareholders the opportunity to buy more shares at a discounted price before they are offered to the public. It’s similar to a special sale where current owners get the first chance to buy extra items at a lower cost, allowing them to increase their investment if they choose. This process matters to investors because it can affect the value of their holdings and their ability to buy new shares at favorable terms.
Series A Rights financial
"each Unit consisting of one share of common stock, one Series A Right to purchase one share of common stock"
Series A rights are the specific protections and privileges attached to the first round of preferred shares sold to early investors, such as priority on company payouts, special voting influence, and the ability to keep their ownership percentage in later financing rounds. Think of them like a VIP ticket that gives holders safer exit priority and stronger say in company decisions, which matters to investors because those rights reduce risk and preserve value.
Series B Rights financial
"and one Series B Right to purchase one share of common stock at $6.00 per share"
Series B rights are the specific protections and privileges attached to shares sold in a company’s Series B financing round, such as priority for getting paid before common shareholders, guaranteed dividend or payout terms, anti-dilution protections, and sometimes board seats or voting powers. Investors care because these rights determine how much money and influence Series B holders will get compared with others—like having a reserved place in line and a bigger slice of the pie if the company is sold or goes public.
stock repurchase program financial
"the Company announced that its Board of Directors has authorized a stock repurchase program under which the Company may repurchase up to $10 million"
A stock repurchase program is when a company buys back its own shares from the market. This can make each remaining share more valuable and shows that the company believes its stock is a good investment. It’s like a business treating its shares like a limited resource, hoping to boost confidence and share prices.
material weaknesses in internal control over financial reporting financial
"concluded that, as of June 30, 2026, our disclosure controls and procedures were not effective due to the material weaknesses in internal control over financial reporting"
A material weakness in internal control over financial reporting is a significant flaw in a company’s processes that increases the likelihood its financial statements could be wrong or misleading. Think of it as a broken checkpoint in an airport security line: if it fails, errors or fraud can pass through undetected. Investors care because these weaknesses raise the risk that reported earnings, assets, or liabilities are inaccurate, which can affect valuation, trust, and investment decisions.
5G ORAN radio products technical
"to acquire intellectual property and other assets used in developing, manufacturing, marketing, and selling 5G ORAN radio products"
Q2 2026 revenue $8,070,379 decrease of 26.81% from Q2 2025 revenue of $11,025,927
Six-month 2026 revenue $13,419,825 decrease of 8.24% from six-month 2025 revenue of $14,625,026
Six-month 2026 gross profit $4,820,878 increase of approximately 135.08% from $2,050,749 in the prior-year period
Q2 2026 net loss $(3,088,512) greater loss than Q2 2025 net loss of $(1,771,625)
Six-month 2026 net loss $(4,610,219) greater loss than six-month 2025 net loss of $(3,612,146)

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

How did AmpliTech Group (AMPG) perform financially in Q2 2026?

AmpliTech reported Q2 2026 revenue of $8,070,379, down 26.81% year over year, and a net loss of $3,088,512. Gross profit improved to $2,254,012, with margin rising to 27.93% as the company shifted away from lower‑margin acquired 5G product sales.

What were AmpliTech Group’s (AMPG) results for the six months ended June 30, 2026?

For the first half of 2026, AmpliTech generated revenue of $13,419,825 and a net loss of $4,610,219. Gross profit increased to $4,820,878, and gross margin improved to 35.92%, but higher SG&A and R&D expenses led to a larger operating loss.

What is AmpliTech Group’s (AMPG) liquidity position as of June 30, 2026?

As of June 30, 2026, AmpliTech held $8,892,838 in cash and cash equivalents, $4,060,107 in marketable securities, and working capital of $22,932,180. Stockholders’ equity totaled $46,753,882, providing a sizeable buffer despite ongoing operating losses.

How much capital did AmpliTech Group (AMPG) raise through recent offerings and rights exercises?

In early 2026 AmpliTech received net proceeds of $8,063,498 from a rights offering and $8,323,748 from a registered direct offering. On July 22, 2026, it added approximately $20,121,994 in net proceeds from the exercise of 4,384,163 Series A Rights.

What stock repurchase program did AmpliTech Group (AMPG) authorize?

On July 7, 2026, AmpliTech’s board authorized a stock repurchase program of up to $10 million of common stock over 24 months. Repurchases may be made via open‑market purchases, block trades, privately negotiated transactions, or Rule 10b5‑1 trading plans.

Does AmpliTech Group (AMPG) have any material weaknesses in internal control?

Yes. Management concluded that as of June 30, 2026, internal control over financial reporting was not effective due to material weaknesses, including documentation gaps, IT general control issues, and limited segregation of duties. The company is continuing its remediation plan.

How is AmpliTech Group’s (AMPG) 5G strategy reflected in recent transactions?

AmpliTech continues investing in 5G, including a $7,000,000 Titan APA for 5G ORAN radio assets and increased R&D spending of $1,877,451 in the first half. Amendment No. 2 reduced the Titan purchase price and restructured remaining payments between cash and restricted stock.
false --12-31 Q2 0001518461 0001518461 2026-01-01 2026-06-30 0001518461 AMPG:CommonStock0.001ParValuePerShareMember 2026-01-01 2026-06-30 0001518461 AMPG:SeriesBRightToPurchaseOneShareOfCommonStockMember 2026-01-01 2026-06-30 0001518461 2026-08-11 0001518461 2026-06-30 0001518461 2025-12-31 0001518461 2026-04-01 2026-06-30 0001518461 2025-04-01 2025-06-30 0001518461 2025-01-01 2025-06-30 0001518461 us-gaap:CommonStockMember 2026-03-31 0001518461 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001518461 us-gaap:RetainedEarningsMember 2026-03-31 0001518461 2026-03-31 0001518461 us-gaap:CommonStockMember 2025-12-31 0001518461 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001518461 us-gaap:RetainedEarningsMember 2025-12-31 0001518461 us-gaap:CommonStockMember 2025-03-31 0001518461 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001518461 us-gaap:RetainedEarningsMember 2025-03-31 0001518461 2025-03-31 0001518461 us-gaap:CommonStockMember 2024-12-31 0001518461 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001518461 us-gaap:RetainedEarningsMember 2024-12-31 0001518461 2024-12-31 0001518461 us-gaap:CommonStockMember 2026-04-01 2026-06-30 0001518461 us-gaap:AdditionalPaidInCapitalMember 2026-04-01 2026-06-30 0001518461 us-gaap:RetainedEarningsMember 2026-04-01 2026-06-30 0001518461 us-gaap:CommonStockMember 2026-01-01 2026-06-30 0001518461 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-06-30 0001518461 us-gaap:RetainedEarningsMember 2026-01-01 2026-06-30 0001518461 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0001518461 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0001518461 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0001518461 us-gaap:CommonStockMember 2025-01-01 2025-06-30 0001518461 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-06-30 0001518461 us-gaap:RetainedEarningsMember 2025-01-01 2025-06-30 0001518461 us-gaap:CommonStockMember 2026-06-30 0001518461 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0001518461 us-gaap:RetainedEarningsMember 2026-06-30 0001518461 us-gaap:CommonStockMember 2025-06-30 0001518461 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001518461 us-gaap:RetainedEarningsMember 2025-06-30 0001518461 2025-06-30 0001518461 AMPG:AmplitechIncandSpecialtyMicrowaveMember AMPG:DomesticSalesMember 2026-04-01 2026-06-30 0001518461 AMPG:AmplitechIncandSpecialtyMicrowaveMember AMPG:DomesticSalesMember 2025-04-01 2025-06-30 0001518461 AMPG:AmplitechIncandSpecialtyMicrowaveMember AMPG:DomesticSalesMember 2026-01-01 2026-06-30 0001518461 AMPG:AmplitechIncandSpecialtyMicrowaveMember AMPG:DomesticSalesMember 2025-01-01 2025-06-30 0001518461 AMPG:AmplitechIncandSpecialtyMicrowaveMember AMPG:InternationalSalesMember 2026-04-01 2026-06-30 0001518461 AMPG:AmplitechIncandSpecialtyMicrowaveMember AMPG:InternationalSalesMember 2025-04-01 2025-06-30 0001518461 AMPG:AmplitechIncandSpecialtyMicrowaveMember AMPG:InternationalSalesMember 2026-01-01 2026-06-30 0001518461 AMPG:AmplitechIncandSpecialtyMicrowaveMember AMPG:InternationalSalesMember 2025-01-01 2025-06-30 0001518461 AMPG:AmplitechIncandSpecialtyMicrowaveMember 2026-04-01 2026-06-30 0001518461 AMPG:AmplitechIncandSpecialtyMicrowaveMember 2025-04-01 2025-06-30 0001518461 AMPG:AmplitechIncandSpecialtyMicrowaveMember 2026-01-01 2026-06-30 0001518461 AMPG:AmplitechIncandSpecialtyMicrowaveMember 2025-01-01 2025-06-30 0001518461 AMPG:SpectrumMember AMPG:DomesticSalesMember 2026-04-01 2026-06-30 0001518461 AMPG:SpectrumMember AMPG:DomesticSalesMember 2025-04-01 2025-06-30 0001518461 AMPG:SpectrumMember AMPG:DomesticSalesMember 2026-01-01 2026-06-30 0001518461 AMPG:SpectrumMember AMPG:DomesticSalesMember 2025-01-01 2025-06-30 0001518461 AMPG:SpectrumMember AMPG:InternationalSalesMember 2026-04-01 2026-06-30 0001518461 AMPG:SpectrumMember AMPG:InternationalSalesMember 2025-04-01 2025-06-30 0001518461 AMPG:SpectrumMember AMPG:InternationalSalesMember 2026-01-01 2026-06-30 0001518461 AMPG:SpectrumMember AMPG:InternationalSalesMember 2025-01-01 2025-06-30 0001518461 AMPG:SpectrumMember 2026-04-01 2026-06-30 0001518461 AMPG:SpectrumMember 2025-04-01 2025-06-30 0001518461 AMPG:SpectrumMember 2026-01-01 2026-06-30 0001518461 AMPG:SpectrumMember 2025-01-01 2025-06-30 0001518461 AMPG:ManufacturingAndEngineeringMember 2026-04-01 2026-06-30 0001518461 AMPG:DistributionMember 2026-04-01 2026-06-30 0001518461 AMPG:CorporatesMember 2026-04-01 2026-06-30 0001518461 AMPG:ManufacturingAndEngineeringMember 2026-06-30 0001518461 AMPG:DistributionMember 2026-06-30 0001518461 AMPG:CorporatesMember 2026-06-30 0001518461 AMPG:ManufacturingAndEngineeringMember 2026-01-01 2026-06-30 0001518461 AMPG:DistributionMember 2026-01-01 2026-06-30 0001518461 AMPG:CorporatesMember 2026-01-01 2026-06-30 0001518461 AMPG:FiveGExpensesMember 2026-04-01 2026-06-30 0001518461 AMPG:MMICDesignExpensesMember 2026-04-01 2026-06-30 0001518461 AMPG:FiveGExpensesMember 2026-01-01 2026-06-30 0001518461 AMPG:MMICDesignExpensesMember 2026-01-01 2026-06-30 0001518461 us-gaap:FairValueInputsLevel1Member us-gaap:MoneyMarketFundsMember 2026-06-30 0001518461 us-gaap:FairValueInputsLevel1Member us-gaap:MoneyMarketFundsMember 2026-01-01 2026-06-30 0001518461 us-gaap:FairValueInputsLevel1Member us-gaap:USTreasurySecuritiesMember 2026-06-30 0001518461 us-gaap:FairValueInputsLevel1Member us-gaap:USTreasurySecuritiesMember 2026-01-01 2026-06-30 0001518461 us-gaap:FairValueInputsLevel1Member 2026-06-30 0001518461 us-gaap:FairValueInputsLevel1Member 2026-01-01 2026-06-30 0001518461 us-gaap:MoneyMarketFundsMember 2026-06-30 0001518461 us-gaap:USTreasurySecuritiesMember 2026-06-30 0001518461 AMPG:LabEquipmentMember 2026-06-30 0001518461 AMPG:LabEquipmentMember 2025-12-31 0001518461 AMPG:ManufacturingEquipmentMember 2026-06-30 0001518461 AMPG:ManufacturingEquipmentMember 2025-12-31 0001518461 us-gaap:AutomobilesMember 2026-06-30 0001518461 us-gaap:AutomobilesMember 2025-12-31 0001518461 AMPG:ComputerEquipmentAndSoftwareMember 2026-06-30 0001518461 AMPG:ComputerEquipmentAndSoftwareMember 2025-12-31 0001518461 us-gaap:LeaseholdImprovementsMember 2026-06-30 0001518461 us-gaap:LeaseholdImprovementsMember 2025-12-31 0001518461 us-gaap:FurnitureAndFixturesMember 2026-06-30 0001518461 us-gaap:FurnitureAndFixturesMember 2025-12-31 0001518461 us-gaap:TradeNamesMember 2026-06-30 0001518461 us-gaap:IntellectualPropertyMember 2026-06-30 0001518461 us-gaap:IntellectualPropertyMember 2026-01-01 2026-06-30 0001518461 us-gaap:CustomerRelationshipsMember 2026-06-30 0001518461 us-gaap:CustomerRelationshipsMember 2026-01-01 2026-06-30 0001518461 AMPG:LicensesMember 2026-06-30 0001518461 AMPG:LicensesMember 2026-01-01 2026-06-30 0001518461 AMPG:DedicatedProductionLineMember 2026-06-30 0001518461 AMPG:DedicatedProductionLineMember 2025-12-31 0001518461 AMPG:FiveGCampusDevelopmentMember 2026-06-30 0001518461 AMPG:FiveGCampusDevelopmentMember 2025-12-31 0001518461 AMPG:IoTSprayerDevelopmentMember 2026-06-30 0001518461 AMPG:IoTSprayerDevelopmentMember 2025-12-31 0001518461 us-gaap:SecuritiesInvestmentMember 2026-06-30 0001518461 us-gaap:SecuritiesInvestmentMember 2025-12-31 0001518461 AMPG:DedicatedProductionLineMember 2026-01-01 2026-06-30 0001518461 AMPG:FiveGCampusDevelopmentMember 2026-01-01 2026-06-30 0001518461 AMPG:IoTSprayerDevelopmentMember 2026-01-01 2026-06-30 0001518461 AMPG:TwoThousandTwentyEquityIncentivePlanMember us-gaap:RestrictedStockUnitsRSUMember AMPG:BoardAdvisorMember 2026-01-05 2026-01-05 0001518461 AMPG:TwoThousandTwentyEquityIncentivePlanMember AMPG:BoardAdvisorMember us-gaap:RestrictedStockUnitsRSUMember 2026-01-05 0001518461 AMPG:TwoThousandTwentyEquityIncentivePlanMember AMPG:BoardAdvisorMember us-gaap:RestrictedStockUnitsRSUMember 2026-04-05 2026-04-05 0001518461 AMPG:TwoThousandTwentyEquityIncentivePlanMember us-gaap:RestrictedStockMember AMPG:OfficersMember 2026-01-30 2026-01-30 0001518461 AMPG:TwoThousandTwentyEquityIncentivePlanMember us-gaap:RestrictedStockMember AMPG:EachOfficerMember 2026-01-30 2026-01-30 0001518461 AMPG:TwoThousandTwentyEquityIncentivePlanMember us-gaap:RestrictedStockUnitsRSUMember 2026-04-20 2026-04-20 0001518461 AMPG:TwoThousandTwentyEquityIncentivePlanMember us-gaap:RestrictedStockUnitsRSUMember 2026-04-20 0001518461 AMPG:EmployeesMember 2026-06-01 2026-06-30 0001518461 AMPG:EmployeesMember srt:MinimumMember 2026-06-01 2026-06-30 0001518461 AMPG:EmployeesMember srt:MaximumMember 2026-06-01 2026-06-30 0001518461 AMPG:EmployeesMember 2026-06-30 0001518461 AMPG:HolderMember 2026-06-01 2026-06-30 0001518461 AMPG:HolderMember 2026-06-30 0001518461 AMPG:ConsultingAgreementMember AMPG:RestrictedStockUnitsAndRestrictedStockAwardsMember 2026-06-09 0001518461 AMPG:ConsultingAgreementMember AMPG:RestrictedStockUnitsAndRestrictedStockAwardsMember 2026-06-01 2026-06-30 0001518461 AMPG:ConsultingAgreementMember AMPG:RestrictedStockUnitsAndRestrictedStockAwardsMember 2026-06-09 2026-06-09 0001518461 AMPG:RightsOfferingMember 2026-01-14 2026-01-14 0001518461 AMPG:RightsOfferingMember AMPG:BasicSubscriptionsMember 2026-01-14 0001518461 AMPG:RightsOfferingMember AMPG:OverSubscriptionsMember 2026-01-14 0001518461 AMPG:RightsOfferingMember AMPG:SeriesARightMember 2026-01-14 0001518461 AMPG:RightsOfferingMember AMPG:SeriesBRightMember 2026-01-14 0001518461 AMPG:RightsOfferingMember 2025-12-31 0001518461 AMPG:RightsOfferingMember 2026-01-01 2026-03-31 0001518461 AMPG:RightsOfferingMember 2026-01-01 2026-06-30 0001518461 AMPG:RegisteredDirectOfferingMember 2026-01-27 2026-01-27 0001518461 AMPG:RegisteredDirectOfferingMember 2026-01-27 0001518461 AMPG:SeriesARightMember AMPG:RegisteredDirectOfferingMember 2026-01-27 0001518461 AMPG:RegisteredDirectOfferingMember AMPG:SeriesBRightMember 2026-01-27 0001518461 AMPG:TwoThousandTwentyEquityIncentivePlanMember us-gaap:EmployeeStockOptionMember 2026-06-30 0001518461 us-gaap:EmployeeStockOptionMember AMPG:TwoThousandTwentyEquityIncentivePlanMember 2026-01-30 2026-01-30 0001518461 us-gaap:EmployeeStockOptionMember AMPG:TwoThousandTwentyEquityIncentivePlanMember 2026-01-30 0001518461 us-gaap:EmployeeStockOptionMember AMPG:TwoThousandTwentyEquityIncentivePlanMember 2026-03-30 2026-03-30 0001518461 us-gaap:EmployeeStockOptionMember AMPG:TwoThousandTwentyEquityIncentivePlanMember 2026-03-30 0001518461 us-gaap:EmployeeStockOptionMember 2026-04-01 2026-06-30 0001518461 us-gaap:EmployeeStockOptionMember 2026-01-01 2026-06-30 0001518461 us-gaap:EmployeeStockOptionMember 2026-06-30 0001518461 us-gaap:WarrantMember 2026-02-19 0001518461 us-gaap:WarrantMember 2026-04-16 0001518461 us-gaap:WarrantMember 2026-04-01 2026-06-30 0001518461 us-gaap:WarrantMember 2026-01-01 2026-06-30 0001518461 us-gaap:WarrantMember 2026-06-30 0001518461 AMPG:TwoThousandTwentyEquityIncentivePlanMember us-gaap:RestrictedStockMember srt:OfficerMember 2026-01-30 2026-01-30 0001518461 AMPG:TwoThousandTwentyEquityIncentivePlanMember us-gaap:RestrictedStockMember srt:OfficerMember 2026-04-20 0001518461 AMPG:ConsultingAgreementMember 2026-06-09 0001518461 AMPG:ConsultingAgreementMember 2026-06-01 2026-06-30 0001518461 AMPG:ConsultingAgreementMember 2026-06-09 2026-06-09 0001518461 AMPG:RestrictedStockUnitsAndRestrictedStockAwardsMember 2026-04-01 2026-06-30 0001518461 AMPG:RestrictedStockUnitsAndRestrictedStockAwardsMember 2026-01-01 2026-06-30 0001518461 AMPG:RestrictedStockUnitsAndRestrictedStockAwardsMember 2026-06-30 0001518461 us-gaap:EmployeeStockOptionMember 2026-04-01 2026-06-30 0001518461 us-gaap:EmployeeStockOptionMember 2026-01-01 2026-06-30 0001518461 us-gaap:WarrantMember 2026-04-01 2026-06-30 0001518461 us-gaap:WarrantMember 2026-01-01 2026-06-30 0001518461 AMPG:SeriesARightMember 2026-04-01 2026-06-30 0001518461 AMPG:SeriesARightMember 2026-01-01 2026-06-30 0001518461 AMPG:SeriesBRightMember 2026-04-01 2026-06-30 0001518461 AMPG:SeriesBRightMember 2026-01-01 2026-06-30 0001518461 AMPG:RestrictedStockUnitsAndRestrictedStockAwardsMember 2026-04-01 2026-06-30 0001518461 AMPG:RestrictedStockUnitsAndRestrictedStockAwardsMember 2026-01-01 2026-06-30 0001518461 us-gaap:EmployeeStockOptionMember 2025-12-31 0001518461 us-gaap:WarrantMember 2025-12-31 0001518461 AMPG:SeriesARightMember 2026-06-30 0001518461 AMPG:SeriesBRightMember 2026-06-30 0001518461 AMPG:RestrictedStockUnitsAndRestrictedStockAwardsMember 2025-12-31 0001518461 AMPG:TitanAssetPurchaseAgreementMember 2025-03-26 2025-03-26 0001518461 AMPG:TitanAssetPurchaseAgreementMember 2025-04-01 2025-04-30 0001518461 srt:ScenarioForecastMember AMPG:TitanAssetPurchaseAgreementMember 2026-09-30 0001518461 srt:ScenarioForecastMember AMPG:TitanAssetPurchaseAgreementMember 2026-07-01 2026-09-30 0001518461 AMPG:TitanAssetPurchaseAgreementMember 2026-03-31 0001518461 AMPG:TitanAssetPurchaseAgreementMember 2025-12-31 0001518461 us-gaap:SubsequentEventMember AMPG:TwoThousandTwentyEquityIncentivePlanMember AMPG:BoardAdvisorMember us-gaap:RestrictedStockUnitsRSUMember 2026-07-06 2026-07-06 0001518461 us-gaap:SubsequentEventMember us-gaap:CommonStockMember 2026-07-07 0001518461 us-gaap:SubsequentEventMember AMPG:SeriesARightMember 2026-07-22 0001518461 us-gaap:SubsequentEventMember AMPG:SeriesARightMember 2026-07-22 2026-07-22 0001518461 us-gaap:SubsequentEventMember 2026-07-22 2026-07-22 0001518461 us-gaap:SubsequentEventMember AMPG:SeriesBRightMember 2026-07-22 0001518461 us-gaap:SubsequentEventMember 2026-08-06 2026-08-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure utr:sqft AMPG:Segment

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2026

 

or

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ______________to ______________

 

Commission File Number 001-40069

 

AmpliTech Group, Inc.

(Exact name of registrant as specified in its charter)

 

Nevada   27-4566352

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification Number)

 

155 Plant Avenue

Hauppauge, NY 11788

(Address of principal executive offices) (Zip Code)

 

(631)-521-7831

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.001 par value per share   AMPG   The Nasdaq Stock Market LLC
Series B Right to purchase one share of common stock   AMPGZ   The Nasdaq Stock Market LLC

 

Indicate by check mark whether registrant (1) has filed all reports to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

 

As of August 11, 2026, the registrant had 30,043,887 shares of common stock, par value $0.001 per share, issued and outstanding.

 

 

 

 
 

 

AMPLITECH GROUP, INC.

 

QUARTERLY REPORT ON FORM 10-Q

June 30, 2026

 

TABLE OF CONTENTS

 

    PAGE
PART I - FINANCIAL INFORMATION 5
   
Item 1. Financial Statements (Unaudited)  5
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 23
     
Item 3. Quantitative and Qualitative Disclosures About Market Risk 28
     
Item 4. Controls and Procedures 28
     
PART II - OTHER INFORMATION 29
     
Item 1. Legal Proceedings 29
     
Item 1A. Risk Factors 29
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 29
     
Item 3. Defaults Upon Senior Securities 29
     
Item 4. Mine Safety Disclosures 29
     
Item 5. Other Information 29
     
Item 6. Exhibits 29
     
SIGNATURES 30

 

2

 

 

Use of Certain Defined Terms

 

Except as otherwise indicated by the context, references in this report to “we,” “us,” “our,” “our Company”, “the Company”, “AmpliTech”, “Specialty” or “SMW” “Spectrum” or “SSM”, “AmpliTech Group MMIC Design Center” or “AGMDC”, “AmpliTech Group True G Speed Services” or “AGTGSS” are the combined business of AmpliTech Group, Inc., and its consolidated subsidiary, AmpliTech, Inc., and AMPG’s divisions Specialty Microwave, Spectrum Semiconductor Materials, AmpliTech Group MMIC Design Center and AmpliTech Group True G Speed Services.

 

3

 

 

CAUTIONARY STATEMENT ON FORWARD-LOOKING INFORMATION

 

This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements discuss matters that are not historical facts. Because they discuss future events or conditions, forward-looking statements may include words such as “anticipate,” “believe,” “estimate,” “intend,” “could,” “should,” “would,” “may,” “seek,” “plan,” “might,” “will,” “expect,” “anticipate,” “predict,” “project,” “forecast,” “potential,” “continue” negatives thereof or similar expressions. Forward-looking statements speak only as of the date they are made, are based on various underlying assumptions and current expectations about the future and are not guarantees. Such statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, level of activity, performance or achievement to be materially different from the results of operations or plans expressed or implied by such forward-looking statements.

 

We cannot predict all the risks and uncertainties. Accordingly, such information should not be regarded as representations that the results or conditions described in such statements or that our objectives and plans will be achieved, and we do not assume any responsibility for the accuracy or completeness of any of these forward-looking statements. These forward-looking statements are found at various places throughout this Quarterly Report on Form 10-Q and include information concerning possible or assumed future results of our operations, including statements about potential acquisition or merger targets; business strategies; future cash flows; financing plans; plans and objectives of management; any other statements regarding future acquisitions, future cash needs, future operations, business plans and future financial results, and any other statements that are not historical facts.

 

These forward-looking statements represent our intentions, plans, expectations, assumptions and beliefs about future events and are subject to risks, uncertainties and other factors. Many of those factors are outside of our control and could cause actual results to differ materially from the results expressed or implied by those forward-looking statements. Considering these risks, uncertainties and assumptions, the events described in the forward-looking statements might not occur or might occur to a different extent or at a different time than we have described. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of the Quarterly Report on Form 10-Q. All subsequent written and oral forward-looking statements concerning other matters addressed in this Quarterly Report on Form 10-Q and attributable to us or any person acting on our behalf are expressly qualified in their entirety by the cautionary statements contained or referred to in this Quarterly Report on Form 10-Q.

 

Except to the extent required by law, we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, a change in events, conditions, circumstances or assumptions underlying such statements, or otherwise.

 

4

 

 

PART I – FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

AmpliTech Group, Inc.

Condensed Consolidated Balance Sheets

 

   June 30,   December 31, 
   2026   2025 
  (Unaudited)     
Assets        
Current Assets          
Cash and cash equivalents  $8,892,838   $4,981,091 
Rights offering subscription proceeds in escrow   113,003    6,704,304 
Accounts receivable   6,253,464    3,349,708 
Inventories, net   9,555,617    8,908,504 
Marketable securities   4,060,107     
Subscription receivable   27,884     
Prepaid expenses and other   2,346,428    1,116,775 
Total Current Assets   31,249,341    25,060,382 
           
Property and equipment, net   3,208,834    2,885,247 
Operating lease right of use assets   3,619,458    3,873,697 
Intangible assets, net   12,304,792    13,144,956 
Goodwill   4,696,883    4,696,883 
Cost method investment   348,250    348,250 
Long-term deposits   3,081,196    1,469,764 
Total Assets  $58,508,754   $51,479,179 
           
Liabilities and Stockholders’ Equity          
Current Liabilities          
Accounts payable and accrued expenses  $4,405,918   $4,653,382 
Customer deposits   214,602    28,337 
Current portion of finance lease obligations   16,203    17,646 
Current portion of operating lease obligations   524,310    499,072 
Refund payable – cancelled stock option exercise   43,125     
Rights offering subscription liability   

113,003

    

6,704,304

 
Contingent liability   3,000,000    3,000,000 
Total Current Liabilities   8,317,161    14,902,741 
           
Long-Term Liabilities          
Finance lease obligations, net of current portion   14,143    21,386 
Operating lease obligations, net of current portion   3,371,568    3,640,491 
Deferred tax liability   52,000    52,000 
Total Liabilities   11,754,872    18,616,618 
           
Commitments and Contingencies        
           
Stockholders’ Equity          
Common stock, par value $0.001, 500,000,000 shares authorized, 25,651,599 and 20,683,095 shares issued and outstanding, respectively   25,652    20,683 
Additional paid-in capital   79,357,731    60,861,160 
Accumulated deficit   (32,629,501)   (28,019,282)
Total Stockholders’ Equity   46,753,882    32,862,561 
           

Total Liabilities and Stockholders’ Equity

  $58,508,754   $51,479,179 

 

See accompanying notes to the condensed consolidated financial statements

 

5

 

 

AmpliTech Group, Inc.

 Condensed Consolidated Statements of Operations

(Unaudited)

 

   2026   2025   2026   2025 
   Three Months Ended   Six Months Ended 
 June 30,   June 30,
   2026   2025   2026   2025 
                 
Revenues  $8,070,379   $11,025,927   $13,419,825   $14,625,026 
                     
Cost of goods sold   5,816,367    10,163,048    8,598,947    12,574,277 
Gross Profit   2,254,012    862,879    4,820,878    2,050,749 
                     
Operating Expenses                     
Selling, general and administrative    4,075,527    2,129,143    7,758,455    4,467,358 
Research and development    1,374,405    658,795    1,877,451    1,398,468 
Total Operating Expenses    5,449,932    2,787,938    9,635,906    5,865,826 
                     
Loss From Operations    (3,195,920)   (1,925,059)   (4,815,028)   (3,815,077)
                     
Other Income (Expense)                    
Other income       88,222        88,222 
Interest income, net   

58,272

    

29,193

    

117,709

    

78,690

 
Unrealized gain (loss) on investments   (13,363)       24,601     
Realized gain on investments   62,499    36,019    62,499    36,019 
Total Other Income   107,408    153,434    204,809    202,931 
                     
Net Loss Before Income Taxes   (3,088,512)   (1,771,625)   (4,610,219)   (3,612,146)
Provision For Income Taxes                 
Net Loss  $(3,088,512)  $(1,771,625)  $(4,610,219)  $(3,612,146)
                     
Net Loss Per Share                    
Basic and diluted   $

(0.12

)  $(0.08)   

(0.19

)  $(0.17)
Weighted-Average Common Shares Outstanding                    
Basic and diluted    

25,447,746

    21,023,328    

24,886,777

    20,660,387 

 

See accompanying notes to the condensed consolidated financial statements

 

6

 

 

AmpliTech Group, Inc.

Condensed Consolidated Statements of Stockholders’ Equity

(Unaudited)

 

   Shares   Value   Capital   Deficit   Equity 
   Three Months Ended June 30, 2026 
   Common Stock   Additional       Total 
   Number of   Par   Paid-In   Accumulated   Stockholders’ 
   Shares   Value   Capital   Deficit   Equity 
                     
Balance, March 31, 2026   25,335,049   $25,335   $77,876,364   $(29,540,989)  $   48,360,710 
                          
Stock-based compensation           919,876        919,876 
Common stock issued upon vesting of RSUs   118,750    119    (119)        
                          
Common stock issued upon exercise of stock options   197,800    198    561,610        561,808 
                          
Net loss               (3,088,512)   (3,088,512)
                          
Balance, June 30, 2026   25,651,599   $25,652   $79,357,731   $(32,629,501)  $46,753,882 

 

   Six Months Ended June 30, 2026 
Balance, December 31, 2025   20,683,095   $20,683   $60,861,160   $(28,019,282)  $32,862,561 
                          
Stock-based compensation           1,552,486        1,552,486 
Common stock issued upon vesting RSUs   272,500    273    (273)        
Common stock issued upon exercise of stock options   197,800    198    561,610        561,808 
Common stock issued in rights offering   2,268,204    2,268    8,061,230        8,063,498 
Common stock issued in registered direct offering   2,230,000    2,230    8,321,518        8,323,748 
Net loss               (4,610,219)   (4,610,219)
Balance, June 30, 2026   25,651,599   $25,652   $79,357,731   $(32,629,501)  $46,753,882 

 

   Three Months Ended June 30,2025 
     Common Stock    Additional         Total 
    Number of    Par    Paid-In    Accumulated    Stockholders’ 
    Shares    Value    Capital    Deficit    Equity  
                          
Balance, March 31, 2025   19,658,960   $19,658   $58,608,356   $(22,852,648)  $35,775,366 
                          
Stock-based compensation           98,426        98,426 
Common stock issued in purchase asset acquisition   914,635    915    1,709,452        1,710,367 
                          
Net loss               (1,771,625)   (1,771,625)
Balance, June 30, 2025   20,573,595   $20,573   $60,416,234   $(24,624,273)  $35,812,534 

 

   Six Months Ended June 30, 2025 
Balance, December 31, 2024   19,656,460   $19,656   $58,483,272   $(21,012,127)  $37,490,801 
                          
Stock-based compensation           223,512        223,512 
Common stock issued upon vesting of RSUs   2,500    2    (2)        
Common stock issued in purchase asset acquisition   914,635    915    1,709,452        1,710,367 
Net loss               (3,612,146)   (3,612,146)
                          
Balance, June 30, 2025   20,573,595   $20,573   $60,416,234   $(24,624,273)  $35,812,534 

 

See accompanying notes to the condensed consolidated financial statements

 

7

 

 

AmpliTech Group, Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

 

   June 30,   June 30, 
   Six Months Ended 
   June 30,
  2026   2025 
Cash Flows from Operating Activities        
Net loss  $(4,610,219)  $(3,612,146)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization   1,073,853    378,218 
Stock-based compensation   1,552,486    223,512 
Change in fair value of marketable securities   

(87,100

)    
Inventory reserve   

(27,000

)    
Operating lease costs   254,239    280,600 
Changes in operating assets and liabilities:          
Accounts receivable   (2,903,756)   (4,108,759)
Inventories   (948,831)   (266,907)
Prepaid expenses and other   (1,394,460)   (579,842)
Long-term deposits   (1,611,432)   (660,000)
Accounts payable and accrued expenses   81,254    4,410,090 
Operating lease obligations   (243,685)   (220,768)
Customer deposits   186,265    (104,235)
Net Cash Used In Operating Activities   (8,678,386)   (4,260,237)
           
Cash Flows from Investing Activities          
Purchases of property and equipment   (557,276)   (487,492)
Cash paid for intangible asset acquisition       (3,500,000)
Net investment in marketable securities   (3,973,007)    
Net Cash Used In Investing Activities   (4,530,283)   (3,987,492)
           
Cash Flows from Financing Activities          
Net proceeds from rights offering   1,637,004     
Net proceeds from registered direct offering   8,323,748     
Proceeds from exercise of stock options, net of subscription receivable   533,924     
Proceeds from cancelled stock option exercise, to be refunded   43,125     
Repayment of finance lease obligations   (8,686)   (10,500)
Net Cash Provided By (Used In) Financing Activities   10,529,115    (10,500)
           
Net change in cash and cash equivalents   (2,679,554)   (8,258,229)
           
Cash, Cash Equivalents, and Restricted Cash          
           
Beginning of the Period   11,685,395    19,315,984 
End of the Period  $9,005,841   $11,057,755 
           
Reconciliation to Consolidated Balance Sheets          

Cash and cash equivalents

   

8,892,838

    

4,981,091

 

Rights offering subscription proceeds in escrow

   

113,003

    

6,704,304

 

Total Cash, Cash equivalents, and Restricted Cash

 

$

9,005,841

  

$

11,057,755

 
           
Supplemental disclosures          
Cash paid for interest  $

4,900 

   $14,746 
Cash paid for income taxes  $

2,414 

   $10,856 
           
Non-Cash Investing and Financing Activities          
Common Stock issued upon vesting of RSUs  $273   $2 
Contingent liability consideration from intangible asset acquisition  $   $3,000,000 
Fair value of common stock issued in intangible asset acquisition  $   $1,710,367 
Subscription receivable from exercise of stock options  $27,884   $ 
Financed purchases of property and equipment  $   $26,868 
Reclassification of subscription liability to stockholders’ equity upon closing of rights offering  $6,591,301   $ 
Reclassification of deferred offering costs to additional paid-in-capital upon closing of rights offering  $164,807   $ 

 

See accompanying notes to the condensed consolidated financial statements

 

8

 

 

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Six Months Ended June 30, 2026 and 2025

(Unaudited)

 

(1) Basis of Presentation and Other Information

 

The accompanying unaudited condensed consolidated financial statements of AmpliTech Group, Inc. (the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q of Regulation S-X. They do not include all the information and footnotes required by U.S. GAAP for complete financial statements. The December 31, 2025 consolidated balance sheet data was derived from audited financial statements but do not include all disclosures required by U.S. GAAP. The interim unaudited condensed consolidated financial statements should be read in conjunction with those consolidated financial statements included in the Form 10-K, as filed with the Securities and Exchange Commission on March 26, 2026. In the opinion of management, all adjustments considered necessary for a fair presentation of the financial statements, consisting solely of normal recurring adjustments, have been made. Operating results for the three and six months ended June 30, 2026 are not necessarily indicative of the results that may be expected for the year ending December 31, 2026.

 

The Company’s significant accounting policies are described in Note 2 to the audited consolidated financial statements included in the Annual Report on Form 10-K for the year ended December 31, 2025. There have been no material changes to the Company’s significant accounting policies during the six months ended June 30, 2026.

 

Recently Adopted Accounting Pronouncements

 

In July 2025, the FASB issued ASU 2025-05, “Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets,” which introduces a practical expedient for the application of the current expected credit loss model to current accounts receivable and contract assets. The amendment is effective for interim and annual periods beginning after December 15, 2025, with early adoption permitted. This amendment is to be applied on a prospective basis. The adoption of ASU 2025-05 did not have a material impact on the Company’s condensed consolidated financial statements.

 

Recently Issued Accounting Pronouncements Not Yet Adopted

 

In November 2024, the FASB issued ASU 2024-03, “Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses,” which requires the disaggregated disclosure of specific expense categories, including purchases of inventory, employee compensation, depreciation, and amortization included in each relevant expense caption presented on the statement of operations. The standard also requires disclosure of qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively, as well as the total amount of selling expenses and an entity’s definition of selling expenses. ASU 2024-03 is effective for annual periods beginning after December 15, 2026, and interim periods beginning after December 15, 2027. The Company is currently evaluating the impact this standard will have on its condensed consolidated financial statements.

 

9

 

 

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Six Months Ended June 30, 2026 and 2025

(Unaudited)

 

In September 2025, the FASB issued ASU 2025-06, “Intangibles – Goodwill and Other – Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software”. This guidance removes all references to project stages throughout ASC 350-40 and clarifies the threshold entities apply to begin capitalizing costs. Under the new standard, cost capitalization should only commence when an entity has committed to funding a software project and it is probable the project will be completed, and the software will be used for its intended function. The amendments are effective for annual reporting periods beginning after December 15, 2027, and interim reporting periods within those annual reporting periods. Entities may apply the guidance using a prospective, retrospective or modified transition approach. Early adoption is permitted as of the beginning of an annual reporting period. The Company is currently evaluating the impact this standard will have on its condensed consolidated financial statements.

 

In December 2025, the FASB issued ASU 2025-11, “Interim Reporting (Topic 270): Narrow-Scope Improvements.” ASU 2025-11 clarifies and improves existing interim reporting guidance by consolidating disclosure requirements within Topic 270 and introducing a disclosure principle requiring entities to disclose events and changes occurring after the most recent annual reporting period that are expected to have a material effect on the entity’s financial condition or results of operations. The ASU does not introduce significant changes to recognition or measurement guidance. The amendments in ASU 2025-11 are effective for interim reporting periods within fiscal years beginning after December 15, 2027, with early adoption permitted. ASU 2025-11 allows for either a prospective or retrospective approach on adoption. The Company is currently evaluating the impact this standard will have on its condensed consolidated financial statements.

 

The Company currently believes there are no other issued and not yet effective accounting standards that are materially relevant to its condensed consolidated financial statements.

 

(2) Disaggregation of Revenues

 

The following table presents sales disaggregated based on geographic regions and for the three and six months ended:

 

   June 30,   June 30,             
   Three Months Ended      Six Months Ended
   June 30,     June 30,
  2026   2025      2026     2025
AmpliTech Inc. and Specialty Microwave                      
Domestic sales  $1,007,803   $644,248    $ 2,307,972   $ 1,358,369
International sales   3,000,853    8,674,208      4,984,222     8,945,623
Total  4,008,656   9,318,456      7,292,194     10,303,992
                       
Spectrum                      
Domestic sales  2,158,073   1,020,653      3,339,686     2,629,042
International sales   1,903,650    686,818      2,787,945     1,691,992
Total  4,061,723   1,707,471      6,127,631     4,321,034
                       
Total sales  $

8,070,379

   $

11,025,927

    $ 13,419,825   $ 14,625,026

 

10

 

 

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Six Months Ended June 30, 2026 and 2025

(Unaudited)

 

(3) Segment Reporting

 

The Company operates in two reportable segments: the manufacturing and engineering segment, which is operated by AmpliTech Inc. and Specialty Microwave; and the distribution segment, which is operated by Spectrum. The manufacturing and engineering segment assembles microwave components, and the distribution segment is a global distributor of integrated circuit packages and lids. The Company’s Chief Executive Officer (“CEO”) is the chief operating decision maker (“CODM”). The CODM assesses segment performance and allocates resources based on segment net income (loss), which is reported in the tables below. The CODM uses segment net income (loss) to evaluate each segment’s operating results, monitor budget-to-actual variances, and determine the allocation of capital, personnel, and research and development resources among the segments. The Company provides general corporate services to its segments; however, these services are not considered when making operating decisions and assessing segment performance. These services are reported under “Corporate” below and include costs associated with executive management, financing activities and public company compliance.

 

The following table presents summary information by segment for the three months ended June 30, 2026:

 

   Manufacturing
and Engineering
   Distribution   Corporate   Total 
Revenue  $4,008,656   $4,061,723   $   $8,070,379 
Cost of goods sold   3,524,032    2,292,335        5,816,367 
Net income (loss)   (2,926,665)   1,133,971    (1,295,818)   (3,088,512)
Research and development (1)   1,374,405            1,374,405 
Total assets   21,850,446    18,232,505    18,425,803    58,508,754 
Depreciation and amortization   323,703    31,169    186,599    541,471 
Interest income, net   13,067        45,205    58,272 

 

11

 

 

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Six Months Ended June 30, 2026 and 2025

(Unaudited)

 

The following table presents summary information by segment for the six months ended June 30, 2026:

 

  

Manufacturing

and Engineering

   Distribution   Corporate   Total 
Revenue  $7,292,194   $6,127,631   $   $13,419,825 
Cost of goods sold   5,213,940    3,385,007        8,598,947 
Net income (loss)   (3,375,601)   1,257,341    (2,491,959)   (4,610,219)
Research and development (2)   1,877,451            1,877,451 
Total assets   21,850,446    18,232,505    18,425,803    58,508,754 
Depreciation and amortization   638,318    62,338    373,197    1,073,853 
Interest income, net   42,206        75,503    117,709 

 

(1) Research and development for the three months ended June 30, 2026 was comprised of $1,077,842 of 5G expenses and $296,563 of MMIC design expenses.
   
(2) Research and development for the six months ended June 30, 2026 was comprised of $1,206,271 of 5G expenses and $671,180 of MMIC design expenses.

 

(4) Marketable Securities

 

The Company’s investments in marketable securities consist of money market funds and U.S. Treasury bills, which are stated at fair value with realized and unrealized gains and losses recognized in other income (expense). Realized and unrealized gains and losses are determined using the specific identification method.

 

Marketable securities as of June 30, 2026 consisted of the following:

 

   June 30, 2026 
   Adjusted Cost   Unrealized Gains   Unrealized Losses   Fair Value 
Level 1 (1)                
Money market funds  $1,530,407   $   $   $1,530,407(2)
U.S. Treasury bills   9,183,171    24,601        9,207,772(2)
Total  $10,713,578   $24,601   $   $10,738,179 

 

(1) Level 1 fair value estimates are based on quoted prices in active markets for identical assets or liabilities.
   
(2)

The money market funds of $1,530,407 and U.S. Treasury bills with a fair value of $5,147,665 (original maturities of less than three months) are included in cash and cash equivalents. The remaining U.S. Treasury bills with a fair value of $4,060,107 (original maturities greater than three months) are classified as marketable securities.

 

12

 

 

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Six Months Ended June 30, 2026 and 2025

(Unaudited)

 

(5) Inventories

 

Inventories are stated at the lower of cost (first-in, first-out) or market (net realizable value) and are reduced by an inventory reserve for items determined to be slow-moving or obsolete. Inventories as of June 30, 2026 and December 31, 2025 consisted of the following:

 

   June 30,   December 31, 
   2026   2025 
Raw materials  $1,867,637   $1,584,086 
Work-in progress   197,448    298,685 
Finished goods   8,682,532    7,916,015 
Finished goods in transit       328,718 
Total inventories   10,747,617    10,127,504 
Less: reserve for obsolescence   (1,192,000)   (1,219,000)
Total inventories, net  $9,555,617   $8,908,504 

 

(6) Property and Equipment

 

Property and Equipment as of June 30, 2026 and December 31, 2025 consisted of the following:

 

   June 30,   December 31, 
   2026   2025 
Lab equipment  $4,822,382   $4,333,676 
Manufacturing equipment   129,745    129,745 
Automobiles   7,335    7,335 
Computer equipment and software   290,326    229,656 
Leasehold improvements   87,322    87,322 
Furniture and fixtures   230,871    222,971 
Total property and equipment   5,567,981    5,010,705 
Less: accumulated depreciation   (2,359,147)   (2,125,458)
Total property and equipment, net  $3,208,834   $2,885,247 

 

Depreciation expense for the three months ended June 30, 2026 and 2025 was $121,389 and $104,525 respectively, of which $86,871 and $73,667, respectively were included in cost of goods sold.

 

Depreciation expense for the six months ended June 30, 2026 and 2025 was $233,690 and $199,352 respectively, of which $163,710 and $147,233, respectively were included in cost of goods sold.

 

13

 

 

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Six Months Ended June 30, 2026 and 2025

(Unaudited)

 

(7) Intangible Assets

 

Intangible assets as of June 30, 2026 consisted of the following:

 

   Gross            
   Carrying Amount   Accumulated Amortization  

Net

Amount

  

Weighted

Average Life

 
Indefinite-lived intangibles                    
Trade name  $514,284   $   $514,284    Indefinite 
Total Indefinite-lived intangibles   514,284       514,284      
                     
Definite-lived intangibles                    
Intellectual property   9,080,288    896,394    8,183,894    9.92 
Customer relationships   3,508,710    631,263    2,877,447    13.33 
Licenses   1,250,000    520,833    729,167    1.20 
Total definite-lived intangibles   13,838,998    2,048,490    11,790,508      
                     
Total intangible assets  $14,353,282   $2,048,490   $12,304,792      

 

Amortization expense for the three months ended June 30, 2026 and 2025 was $420,082 and $151,633, respectively.

 

Amortization expense for the six months ended June 30, 2026 and 2025 was $840,163 and $178,866 respectively.

 

Estimated amortization expense for intangible assets for the next five years consists of the following as of June 30, 2026:

 

 

      
    Amount 
2026 (remaining)  $840,164 
2027   1,471,995 
2028   1,055,328 
2029   1,055,328 
2030   1,055,328 
Thereafter   6,312,365 
Total estimated amortization expense  $11,790,508 

 

(8) Long-Term Deposits

 

Long-term deposits represent advance payments made by the Company in connection with the establishment of dedicated production capacity, the development of the Company’s 5G technology campus, the development of the Company’s first consumer product (an Internet of Things (“IoT”) sprayer that uses sensors, software, and internet connectivity to automate spraying for disinfecting and deodorizing applications), and security deposits associated with the Company’s facility leases. None of the production line, 5G campus, or IoT sprayer development assets are operational as of June 30, 2026. The deposits will be reclassified to property and equipment, intangible assets, or other appropriate asset categories upon completion and acceptance of the underlying assets and commencement of operations.

 

Long-term deposits as of June 30, 2026 and December 31, 2025 consisted of the following:

 

   June 30,   December 31, 
   2026   2025 
Dedicated production line deposits  $2,473,824   $1,173,824 
5G campus development deposits   288,178    181,766 
IoT sprayer development deposits   205,020     
Security deposits   114,174    114,174 
Total long-term deposits  $3,081,196   $1,469,764 

 

During the six months ended June 30, 2026, the Company made additional advance payments totaling $1,611,432, consisting of $1,300,000 toward the dedicated production line, $106,412 toward the 5G technology campus, and $205,020 toward the development of the IoT sprayer. Security deposits were unchanged during the period.

 

14

 

 

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Six Months Ended June 30, 2026 and 2025

(Unaudited)

 

(9) Leases

 

Operating leases and finance leases as of June 30, 2026 and December 31, 2025 consisted of the following:

 

   June 30, 2026   December 31, 2025 
Operating leases          
Assets          
ROU operating lease assets  $3,619,458   $3,873,697 
           
Liabilities          
Current portion of operating lease  $524,310   $499,072 
Operating lease, net of current portion   3,371,568    3,640,491 
Total operating lease liabilities  $3,895,878   $4,139,563 
           
Finance leases          
Assets          
Property and equipment, gross  $80,426   $80,426 
Accumulated depreciation   (48,548)   (41,848)
Property and equipment, net  $31,878   $38,578 
           
Liabilities          
Current portion of finance leases  $16,203   $17,646 
Finance lease, net of current portion   14,143    21,386 
Total finance leases  $30,346   $39,032 

 

The weighted average remaining lease term and weighted average discount rate on June 30, 2026 are as follows:

 

 

June 30,

2026

 
Weighted-average remaining lease term (years)     
Operating leases   6.57 
Financing leases   2.25 
Weighted-average discount rate     
Operating leases   6.23%
Financing leases   7.89%

 

As of June 30, 2026, future minimum lease payments under operating lease liabilities were as follows:

 

      
    Amount 
2026 (remaining)  $372,911 
2027   757,483 
2028   779,311 
2029   781,351 
2030   510,606 
Thereafter   1,470,323 
Total operating lease payments   4,671,985 
Less imputed interest   (776,107)
Total operating lease obligations   3,895,878 
Less current operating lease obligations   (524,310)
Long-term operating lease obligations  $3,371,568 

 

15

 

 

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Six Months Ended June 30, 2026 and 2025

(Unaudited)

 

As of June 30, 2026, future minimum lease payments under finance leases were as follows:

 

      
    Amount 
2026 (remaining)  $10,041 
2027   12,094 
2028   8,100 
2029   3,375 
Total finance lease payments   33,610 
Less imputed interest   (3,264)
Total finance lease obligations   30,346 
Less current finance lease obligations   (16,203)
Long-term finance lease obligations  $14,143 

 

(10) Stockholders’ Equity

 

Common Stock

 

On January 5, 2026, 15,000 restricted stock units at an exercise price of $3.65 were issued to a board advisor, vesting in equal quarterly installments of 3,750 shares beginning on the grant date. The first and second installment of 3,750 shares were issued on January 5, 2026 and April 5, 2026. The restricted stock units were granted under the Company’s 2020 Equity Incentive Plan (the “2020 Plan”).

 

On January 30, 2026, the Company granted restricted stock awards under the 2020 Plan to the officers of the Company for an aggregate of 150,000 shares of common stock (50,000 each) valued at $456,000. These restricted stock awards vested immediately.

 

On April 20, 2026, the Company entered into a consulting agreement pursuant to which we agreed to issue 15,000 restricted stock units at an exercise price of $2.00. The restricted stock units were issued pursuant to the Company’s 2020 Plan.

 

During the six months ended June 30, 2026, employees exercised a total of 197,800 stock options at various exercise prices ranging from $1.02 to $3.88 per share, resulting in total proceeds of $561,808, of which $533,924 was received in cash and $27,884 is recorded as a subscription receivable in the condensed consolidated balance sheet as of June 30, 2026. In addition, during the six months ended June 30, 2026, a holder exercised 25,000 stock options in excess of the holder’s vested entitlement. The excess shares were subsequently cancelled by the Company’s transfer agent, and the related exercise proceeds of $43,125 are recorded as a refund payable in the condensed consolidated balance sheet as of June 30, 2026.

 

On June 9, 2026, the Company entered into a consulting agreement pursuant to which we agreed to issue an aggregate of 800,002 shares of common stock in installments as compensation for services pursuant to and subject to the terms of the consulting agreement. The initial 100,000 shares of common stock were issued in June 2026, and the remaining balance of 700,002 shares of common stock will be issued in monthly installments of 77,778 commencing in October 2026 for continued services.

 

16

 

 

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Six Months Ended June 30, 2026 and 2025

(Unaudited)

 

Rights Offering

 

On January 14, 2026, the Company closed on a rights offering of transferable Unit Subscription Rights that had been distributed to eligible holders of the Company’s common stock and certain warrant holders as of the November 10, 2025 record date. The Unit Subscription Rights expired on January 9, 2026, and the Company received aggregate gross proceeds of $9,072,816 from 1,247,086 basic subscriptions and 1,021,118 over-subscriptions. As a result of the closing, the Company issued 2,268,204 Units, each Unit consisting of one share of common stock, one Series A Right to purchase one share of common stock at $5.00 per share (expiring July 18, 2026), and one Series B Right to purchase one share of common stock at $6.00 per share (expiring November 20, 2026).

 

Of the gross proceeds, $6,704,304 had been received in escrow during 2025 and was reflected as rights offering proceeds held in escrow with a corresponding subscription liability in the consolidated balance sheet at December 31, 2025; the remaining $2,368,512 was received during the three months ended March 31, 2026. Total cash issuance costs of $1,009,318 (consisting of placement-agent fees and other offering expenses) were incurred, of which $164,807 had been paid in 2025 and capitalized as deferred offering costs at December 31, 2025. Net proceeds from the rights offering were $8,063,498.

 

The Series A Rights and Series B Rights commenced trading on the Nasdaq Stock Market under the symbols “AMPGR” and “AMPGZ,” respectively, on February 3, 2026.

 

The Company evaluated the Unit Subscription Rights, Series A Rights, and Series B Rights as freestanding equity instruments under ASC 480, “Distinguishing Liabilities from Equity,” and ASC 815-40, “Derivatives and Hedging—Contracts in an Entity’s Own Equity,” and determined that all instruments qualify for equity classification. Accordingly, the gross proceeds were recorded to stockholders’ equity.

 

In connection with the Rights Offering, the Company determined that a bonus element existed under ASC 260 “Earnings Per Share,” because the implied subscription price attributable to the common stock component of the $4.00 Unit price, after deducting the fair values of the Series A Right and Series B Right as of November 6, 2025, the last trading day prior to the November 7, 2025 ex-dividend date, was below the market price of the Company’s common stock on that date. Accordingly, the weighted-average common shares outstanding for all periods presented prior to the ex-dividend date have been retroactively adjusted by a factor of 1.03 in accordance with ASC 260-10-55-14.

 

During the three months ended June 30, 2026, holders of Series A Rights exercised a portion of their Series A Rights in advance of the July 18, 2026 expiration date. Because the shares of common stock underlying the Series A Rights are not issued until the expiration date, the related subscription proceeds of $113,003 received as of June 30, 2026 are reflected as rights offering subscription proceeds in escrow, with a corresponding rights offering subscription liability, in the condensed consolidated balance sheet.

 

17

 

 

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Six Months Ended June 30, 2026 and 2025

(Unaudited)

 

Registered Direct Offering

 

On January 27, 2026, the Company closed a registered direct offering with five institutional investors, issuing 2,230,000 Units at $4.055 per Unit, with each Unit consisting of one share of common stock, one Series A Right to purchase one share of common stock at $5.00 per share (expiring July 18, 2026), and one Series B Right to purchase one share of common stock at $6.00 per share (expiring November 20, 2026), on substantially the same terms as the Series Rights issued in the rights offering described above. The Company received gross proceeds of $9,042,650 and net proceeds of $8,323,748 after deducting cash issuance costs of $718,902, consisting of a 6.0% placement-agent fee and other offering expenses (including up to $15,000 of accountable expense reimbursement to the placement agent).

 

Consistent with the conclusion reached in connection with the rights offering described above, the Company evaluated the common stock, the Series A Rights, and the Series B Rights as freestanding equity instruments under ASC 480 and ASC 815-40 and concluded that all instruments qualify for equity classification. Accordingly, the gross proceeds were recorded to stockholders’ equity.

 

2020 Equity Incentive Plan

 

The 2020 Plan permits the grant of Incentive Stock Options, Nonstatutory Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Performance Units, Performance Shares, and other stock or cash awards as the Board of Directors may determine.

 

As of June 30, 2026, all outstanding stock options were issued according to the Company’s 2020 Plan, and there remained 5,343,425 shares of common stock available for future issuance under the 2020 Plan.

 

Stock Options

 

On January 30, 2026, as per the terms of the employment agreements, the Company granted the officers stock options to purchase 200,000 shares of common stock each according to the Company’s 2020 Plan. The options shall be subject to service-based vesting with twenty-five percent (25%) of the shares underlying the option vesting on the first anniversary of the date of grant and the remaining seventy-five percent (75%) vesting in thirty-six (36) equal monthly installments if the executive remains in continuous employment or service with the Company on each applicable vesting date. The Company has calculated these options estimated fair market value at $1,644,300 using the Black-Scholes model, with the following assumptions: expected term of 7.01 years, stock price of $3.04, exercise price of $3.04, volatility of 119.5%, risk-free rate of 4.01%, and no forfeiture rate.

 

On March 30, 2026, the Company granted multiple employees ten-year stock options to purchase 64,800 shares of common stock according to the Company’s 2020 Plan, that shall vest quarterly over a period of two years commencing on June 30, 2026. The stock options have an exercise price of $1.76 per share. The Company has calculated these options estimate fair market value at $98,500 using the Black-Scholes model, with the following assumptions: expected term of 6.01 years, stock price of $1.76, exercise price of $1.76, volatility of 116.2%, risk-free rate of 4.07%, and no forfeiture rate.

 

18

 

 

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Six Months Ended June 30, 2026 and 2025

(Unaudited)

 

Below is a table summarizing the changes in stock options outstanding for the six months ended June 30, 2026:

 

 

   Number of   Weighted-Average 
   Options   Exercise Price 
Outstanding at December 31, 2025   1,254,000   $2.29 
Granted   664,800   2.92 
Exercised   (197,800)  2.84 
Forfeited or expired   (38,500)  4.59 
Outstanding at June 30, 2026   1,682,500   $2.42 
Exercisable at June 30, 2026   729,128   $2.22 

 

Stock-based compensation expense related to stock options of $192,238 and $342,422 was recorded for the three and six months ended June 30, 2026. As of June 30, 2026, the remaining unrecognized compensation cost related to non-vested stock options is $2,017,943 and is expected to be recognized over 3.59 years. The outstanding stock options have a weighted-average remaining contractual life of 5.56 years and a total intrinsic value of $7,622,297.

 

Warrants

 

On February 19, 2026, the Company’s previously listed warrants (Nasdaq: AMPGW) expired in accordance with their original terms at 5:00 p.m. Eastern Time. Trading in the warrants ceased at the close of market on February 18, 2026, after which the warrants were removed from listing on Nasdaq. Prior to their expiration, there were a total of 1,366,442 warrants outstanding with each warrant granting the holder the right to purchase one share of common stock at $7.00 per share.

 

The private placement warrants issued by the Company in April 2021 expired in accordance with their terms at 5:00 p.m. Eastern Time on April 16, 2026. Prior to expiration, 1,900,500 warrants were outstanding, each exercisable for one share of the Company’s common stock at an exercise price of $8.48 per share. In accordance with the terms of the warrants, any warrants that remained unexercised as of the expiration date automatically expired and are no longer exercisable or of any value.

 

19

 

 

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Six Months Ended June 30, 2026 and 2025

(Unaudited)

 

Below is a table summarizing the changes in warrants outstanding for the six months ended June 30, 2026:

 

Schedule of Warrants Outstanding

   

Number of

Warrant

and Series

Rights

   

Weighted-

Average

Exercise

Price

 
Outstanding at December 31, 2025     3,296,942 (1)   $ 7.83  
Granted     8,996,408 (2)     5.50  
Forfeited or expired     (3,266,942) (1)     7.86  
Outstanding at June 30, 2026     9,026,408     $ 5.50  
Exercisable at June 30, 2026     9,026,408     $ 5.50  

 

(1) Represents warrants.
(2) Represents 4,498,204 Series A Rights and 4,498,204 Series B Rights issued in connection with the rights offering and registered direct offering described above.

 

Stock-based compensation expense related to warrants of $0 was recorded for the three and six months ended June 30, 2026. As of June 30, 2026, the remaining unrecognized compensation cost related to non-vested warrants is $0. The outstanding warrants have a weighted-average remaining contractual life of 0.22 years and a total intrinsic value of $13,193,556.

 

Restricted Stock Units and Restricted Stock Awards

 

On January 5, 2026, 15,000 restricted stock units (“RSUs”) with a grant-date fair value of $3.65 per share were issued to a board advisor, vesting in equal quarterly installments of 3,750 shares beginning on the grant date. The first and second installments of 3,750 shares were issued on January 5, 2026 and April 5, 2026. These RSUs were issued pursuant to the Company’s 2020 Plan.

 

On January 30, 2026, the Company granted restricted stock awards (“RSAs”) to the officers of the Company for an aggregate of 150,000 shares of common stock (50,000 each) with a grant-date fair value of $3.04 per share, which vested immediately. These RSAs were issued pursuant to the Company’s 2020 Plan.

 

On April 20, 2026, the Company entered into a consulting agreement pursuant to which the Company agreed to issue 15,000 RSUs with a grant-date fair value of $2.00 per share, which vested immediately. These RSUs were issued pursuant to the Company’s 2020 Plan.

 

On June 9, 2026, the Company entered into a consulting agreement pursuant to which the Company agreed to issue an aggregate of 800,002 shares of common stock as compensation for services pursuant to and subject to the terms of the consulting agreement. The initial 100,000 shares of common stock were issued in June 2026 and vested immediately. The remaining 700,002 shares of common stock will be issued in nine equal monthly installments of 77,778 shares commencing in October 2026,subject to continued services. The aggregate grant-date fair value of the award was $5,472,014, based on the Company’s closing stock price of $6.84 per share on the grant date.

 

20

 

 

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Six Months Ended June 30, 2026 and 2025

(Unaudited)

 

Below is a table summarizing the changes in RSUs and RSAs outstanding for the six months ended June 30, 2026:

 

 

  

Number of

RSUs / RSAs

  

Weighted-Average

Grant Date

Value

 
Outstanding at December 31, 2025      $ 
Granted   980,002   6.14 
Vested   (272,500)  4.39 
Outstanding at June 30, 2026   707,502   $6.81 

 

Stock-based compensation expense related to RSUs and RSAs of $727,638 and $1,210,064 was recorded for the three and six months ended June 30, 2026. As of June 30, 2026, the remaining unrecognized compensation cost related to non-vested RSUs and RSAs is $4,802,700. The outstanding RSUs and RSAs have a weighted-average remaining contractual life of 0.94 years and an aggregate intrinsic value of $4,924,214.

 

Common Stock Equivalents

 

For the three and six months ended June 30, 2026, all potential common shares were excluded from the diluted loss per share calculation as their effect would be antidilutive due to the Company’s net loss position. As of June 30, 2026, the Company had 1,682,500 stock options, 30,000 warrants, 4,498,204 Series A Rights, 4,498,204 Series B Rights, and 707,502 unvested RSUs and RSAs outstanding, representing 11,416,410 potential common shares excluded from the diluted loss per share calculation.

 

(11) Commitments and Contingencies

 

Contingent Liability – Intangible Asset Acquisition

 

On March 26, 2025, the Company entered into an asset purchase agreement (the “Titan APA”) to acquire intellectual property and other assets used in developing, manufacturing, marketing, and selling 5G ORAN radio products, subject to certain customer purchase order conditions. The aggregate purchase price is $8,000,000, consisting of $4,000,000 in cash and $4,000,000 in restricted shares of common stock, payable across two milestones.

 

Upon achievement of the First Milestone in April 2025, the Company paid $3,500,000 in cash and issued 914,635 shares of restricted common stock to Titan with a fair value of $1,710,367. Under the Titan APA, the Company agreed to pay the remaining $500,000 in cash and $2,500,000 in restricted shares of common stock will be paid upon achievement of the Second Milestone, which is expected to occur in the third quarter of 2026, and is recorded as a $3,000,000 contingent liability in the condensed consolidated balance sheets at June 30, 2026 and December 31, 2025.

 

Under the Titan APA, the parties have customary indemnification obligations, and Titan and its affiliate have agreed not to engage in certain competitive activities for a period of ten years following the closing.

 

21

 

 

AmpliTech Group, Inc.

Notes To Condensed Consolidated Financial Statements

For the Six Months Ended June 30, 2026 and 2025

(Unaudited)

 

Legal Proceedings

 

From time to time, the Company may be involved in various legal proceedings and claims arising in the ordinary course of business. As of June 30, 2026, the Company was not a party to any legal proceedings the outcome of which, individually or in the aggregate, would be expected to have a material adverse effect on the Company’s financial position, results of operations, or cash flows.

 

(12) Subsequent Events

 

Vesting of RSU Installment

 

In connection with the 15,000 restricted stock units issued to a board advisor in January 2026, the third installment of 3,750 shares was issued on July 6, 2026. The restricted stock units were issued pursuant to the Company’s 2020 Plan.

 

Termination of Equity Distribution Agreement

 

On July 7, 2026, the Company provided notice to Maxim Group LLC (“Maxim”), as Agent, that it was terminating the Equity Distribution Agreement dated March 21, 2025, between the Company and Maxim effective immediately.

 

Adoption of Stock Repurchase Program

 

On July 7, 2026, the Company announced that its Board of Directors has authorized a stock repurchase program under which the Company may repurchase up to $10 million of its outstanding common stock over the next 24 months. Under the program, repurchases may be made from time to time through open market purchases, privately negotiated transactions, block trades, or other means in accordance with applicable federal securities laws, including Rule 10b-18 under the Securities Exchange Act of 1934, as amended. The Company may also enter into a trading plan under Rule 10b5-1. The timing, manner, price, and amount of any repurchases will be determined by the Company at its discretion and will depend on a variety of factors, including market conditions, the trading price of the Company’s common stock, applicable legal and regulatory requirements, and other considerations. The program does not obligate the Company to acquire any particular number of shares, and it may be suspended, modified, or discontinued at any time without prior notice.

 

Closing of Series A Rights

 

On July 22, 2026, the Company closed on the Series A Rights (the “Closing”), which expired on July 18, 2026. Each Series A Right entitled the holder to purchase one share of common stock of the Company at an exercise price of $5.00 per share. Of the 4,498,204 Series A Rights outstanding, 4,384,163 were exercised and 114,041 expired unexercised and were automatically cancelled. The Company received approximately $21,920,815 in gross proceeds from the exercise of the Series A Rights and issued 4,384,163 shares of common stock. Gross proceeds include $113,003 received and held in escrow as of June 30, 2026, at which date a corresponding rights offering subscription liability was recorded. Net proceeds from the Closing were approximately $20,121,994 after deducting fees and expenses of Moody Capital, as placement agent, and the Company’s other offering expenses. The Series A Rights ceased trading on Nasdaq following their expiration. The Series B Rights, exercisable at $6.00 per share, remain outstanding and continue to trade on Nasdaq under the symbol “AMPGZ” until their expiration on November 20, 2026.

 

Amendment No. 2 to Titan APA

 

On August 6, 2026, the Company entered into Amendment No. 2 to the Titan APA (the “Amendment”) with Titan and Titan’s affiliate (the “Affiliate”). The Amendment was entered into as a result of Titan’s and the Affiliate’s substantial delinquency in timely delivering products to the Company, which has caused the Company substantial delays in developing its products, including the delivery of documentation and drawing packages for the 5G ORAN radio products. Pursuant to the Amendment, the parties agreed, among other things, to (i) decrease the aggregate purchase price from $8,000,000 to $7,000,000 and (ii) amend the form of payment of the remaining purchase price. Subject to the transfer of the fully developed design package for the 5G ORAN radio technology (the “Transfer”) and acknowledgment by the Company’s manufacturing partner that the documentation and drawing package is suitable for full production purposes, the remaining unpaid purchase price of $2,000,000 will be paid as follows: (i) $1,000,000 in cash and (ii) $1,000,000 in restricted common stock of the Company based on the volume-weighted average price of the Company’s common stock over the thirty (30) trading days preceding the date of the Transfer. Pursuant to the Amendment, Titan was released from substantially all of its remaining covenants and indemnification obligations under the Titan APA, and the Affiliate assumed such obligations. The Company did not waive any rights or claims it may have against Titan or the Affiliate arising prior to the date of the Amendment.

 

22

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The following discussion provides information which management believes is relevant to an assessment and understanding of our results of operations and financial condition. The discussion should be read along with our financial statements and notes thereto contained elsewhere in this Quarterly Report on Form 10-Q. The following discussion and analysis contain forward-looking statements, which involve risks and uncertainties. Our actual results may differ significantly from the results, expectations and plans discussed in these forward-looking statements.

 

Business Overview

 

AmpliTech Group Inc. (“AMPG,” “AmpliTech” or the “Company”), incorporated in 2010 in the State of Nevada, is the parent company of AmpliTech, Inc., and the Company’s divisions, Specialty Microwave, Spectrum Semiconductor Materials, AmpliTech Group MMIC Design Center (“AGMDC”) and AmpliTech Group True G Speed Services (“AGTGSS”).

 

AmpliTech, Inc. designs, engineers and assembles micro-wave component-based amplifiers that meet individual customer specifications. Our products consist of Radio Frequency (“RF”) amplifiers and related subsystems, operating at multiple frequencies from 50kHz to 44GHz, including low noise amplifiers (“LNA”), medium power amplifiers, cryogenic amplifiers, and custom assembly designs for the global satellite communications, telecom (5G & IoT), space, defense, and quantum computing markets. We also offer non-recurring engineering services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time plus material basis. We have both domestic and international customers in such industries as aerospace, governmental, defense and commercial satellite.

 

Specialty Microwave designs and manufactures state-of- the-art precision SATCOM microwave components, RF subsystems and specialized electronic assemblies for the military and commercial markets, flexible and rugged waveguides, wave guide adapters and more.

 

On December 15, 2021, we acquired substantially all of the assets of Spectrum Semiconductor Materials Inc. (“SSM”), a globally authorized distributor of integrated circuit (IC) packaging and lids for semiconductor device assembly, prototyping, testing, and production requirements founded in 1990 and headquartered in San Jose, CA.

 

In 2021, the Company opened AGMDC, a monolithic microwave integrated circuits (“MMIC”) chip design center, in Texas and has started to implement several of its proprietary amplifier designs into MMIC components. MMICs are semiconductor chips used in high-frequency communications applications. MMICs are widely desired for power amplification solutions to service emerging technologies, such as phased array antennas and quantum computing. MMICs carry a smaller footprint enabling them to be incorporated into a broader array of systems while reducing costs. AGMDC designs, develops and manufactures state-of-the-art signal processing components for satellite and 5G communications networks, defense, space and other commercial applications, allowing the Company to market its products to wider base of customers requiring high technology in smaller packages.

 

In August 2022, we formed our AGTGSS division to enable “true G speeds” to the industry. AGTGSS’ main function will be to plan and configure 5G radio systems and make them O-RAN compliant. AGTGSS will implement AmpliTech’s low noise amplifier devices in these systems to promote greater coverage, longer range and faster speeds.

 

On March 26, 2025, we entered into an asset purchase agreement (as amended, “Titan APA”), with Titan Crest, LLC, a Delaware limited liability company (“Titan”), and its affiliate, to purchase certain assets including intellectual property used in developing, manufacturing, marketing and selling products that use radio frequency technology (“5G ORAN radio products”).

 

Our mission is to patent our proprietary IP and trade secrets that were used in small volume niche markets and expand our capabilities through strategic partnerships, joint ventures, mergers/acquisitions with key industry leaders in the 5G/6G, quantum computing, and cybersecurity markets. We believe this will enable us to scale up our products and revenue by developing full systems and subsystems with our unique technology as a core component, which we expect will position us as a global leader in these rapidly emerging technology sectors and addresses large volume markets as well, such as cellphone handsets, laptops, server networks, and many other applications that improve everyday quality of life.

 

The Company’s research and development initiative to expand its product line of low noise amplifiers to include its new 5G and wireless infrastructure products, cryogenic amplifiers and MMIC designs is progressing significantly. Our combined engineering and manufacturing resources are expected to complement the development of new subsystems for satellite, wireless, and 5G infrastructures, as well as advanced military and commercial markets.

 

23

 

 

Recent Developments

 

Termination of ATM Offering

 

On July 7, 2026, we provided notice to Maxim Group LLC (“Maxim”), as Agent, that we were terminating the Equity Distribution Agreement dated March 21, 2025, between us and Maxim effective immediately.

 

Adoption of Stock Repurchase Program

 

On July 7, 2026, we announced that our Board of Directors has authorized a stock repurchase program under which we may repurchase up to $10 million of our outstanding common stock over the next 24 months. Under the program, repurchases may be made from time to time through open market purchases, privately negotiated transactions, block trades, or other means in accordance with applicable federal securities laws, including Rule 10b-18 under the Securities Exchange Act of 1934, as amended. We may also enter into a trading plan under Rule 10b5-1. The timing, manner, price, and amount of any repurchases will be determined by us at our discretion and will depend on a variety of factors, including market conditions, the trading price of our common stock, applicable legal and regulatory requirements, and other considerations. The program does not obligate us to acquire any particular number of shares, and it may be suspended, modified, or discontinued at any time without prior notice.

 

Closing of Series A Rights

 

On July 22, 2026, we closed on the Series A Rights (the “Closing”), which expired on July 18, 2026. Each Series A Right entitled the holder to purchase one share of our common stock at an exercise price of $5.00 per share. Of the 4,498,204 Series A Rights outstanding, 4,384,163 were exercised and 114,041 expired unexercised and were automatically cancelled. We received approximately $21,920,815 in gross proceeds from the exercise of the Series A Rights and issued 4,384,163 shares of common stock. Gross proceeds include $113,003 received and held in escrow as of June 30, 2026, at which date a corresponding rights offering subscription liability was recorded. Net proceeds from the Closing were approximately $20,121,994 after deducting fees and expenses of Moody Capital, as placement agent, and our other offering expenses. The Series A Rights ceased trading on Nasdaq following their expiration. The Series B Rights, exercisable at $6.00 per share, remain outstanding and continue to trade on Nasdaq under the symbol “AMPGZ” until their expiration on November 20, 2026.

 

Amendment No. 2 to Titan APA

 

On August 6, 2026, we entered into Amendment No. 2 to the Titan APA (the “Amendment”) with Titan and Titan’s affiliate (the “Affiliate”). The Amendment was entered into as a result of Titan’s and the Affiliate’s substantial delinquency in timely delivering products to us, which has caused us substantial delays in developing our products, including the delivery of documentation and drawing packages for the 5G ORAN radio products. Pursuant to the Amendment, the parties agreed, among other things, to (i) decrease the aggregate purchase price from $8,000,000 to $7,000,000 and (ii) amend the form of payment of the remaining purchase price. Subject to the transfer of the fully developed design package for the 5G ORAN radio technology (the “Transfer”) and acknowledgment by our manufacturing partner that the documentation and drawing package is suitable for full production purposes, the remaining unpaid purchase price of $2,000,000 will be paid as follows: (i) $1,000,000 in cash and (ii) $1,000,000 in our restricted common stock based on the volume-weighted average price of our common stock over the thirty (30) trading days preceding the date of the Transfer. Pursuant to the Amendment, Titan was released from substantially all of its remaining covenants and indemnification obligations under the Titan APA, and the Affiliate assumed such obligations. We did not waive any rights or claims we may have against Titan or the Affiliate arising prior to the date of the Amendment.

 

Corporate Information

 

Our principal executive offices are located at 155 Plant Avenue, Hauppauge, NY 11788. Our telephone number is (631) 521-7831. Our corporate website is www.amplitechinc.com. The information on our website is not a part of or incorporated in this report.

 

Results of Operations

 

For the Three Months Ended June 30, 2026 and June 30, 2025

 

Revenues

 

Sales decreased from $11,025,927 for the three months ended June 30, 2025, to $8,070,379 for the three months ended June 30, 2026, a decrease of $2,955,548 or approximately 26.81%. Distribution sales increased to $4,061,722 from $1,707,471 in the same period in the prior year, representing a significant year-over-year increase of $2,354,251. The growth was primarily attributable to higher sales volumes through distribution channels and continued expansion of the distribution business. The year-over-year decrease in 5G sales is primarily attributable to the acquired revenue recognized in the same period in the prior year related to the fulfillment of sales orders obtained through the Titan asset acquisition. Sales in the amplifier and related passive microwave components and subsystems division increased by $328,260 or 42.68%.

 

24

 

 

Cost of Goods Sold and Gross Profit

 

Cost of goods sold decreased from $10,163,048 for the three months ended June 30, 2025, to $5,816,367 for the three months ended June 30, 2026, a decrease of $4,346,681 or 42.77%. Cost of goods sold decreased compared to the same period in the prior year primarily due to lower sales volumes. The same period in the prior year included the fulfillment of acquired 5G product sales resulting from the asset acquisition, which increased both sales and the related cost of goods sold. Gross profit for the three months ended June 30, 2025 was $862,879 compared to $2,254,012 for the three months ended June 30, 2026, an increase of $1,391,133, or 161.22 %. Gross profit as a percentage of sales increased to 27.93% from 7.83%.

 

Selling, General and Administrative Expenses

 

Selling, general and administrative expenses increased to $4,075,527 for the three months ended June 30, 2026, from $2,129,143 for the three months ended June 30, 2025, an increase of $1,946,384, or approximately 91.42%. The increase was primarily attributable to higher parent company expenses, including increased amortization expense, legal fees and stock-based compensation. Selling, general and administrative expenses also increased as a result of greater investments in marketing and business development activities, including participation in additional industry trade shows such as the IMS and Network X trade shows, as well as expanded promotional initiatives designed to enhance brand awareness, strengthen customer engagement, and support business growth. The increase also reflects the engagement of two consultants to expand marketing and business development efforts for the Company’s 5G product portfolio.

 

Research and Development Expenses

 

Research and development expenditures are charged to operations as incurred. The major components of research and development costs include salaries and benefits, consultants, outside service, and supplies.

 

Research and development expenses increased to $1,374,405 for the three months ended June 30, 2026, from $658,795 for the three months ended June 30, 2025, an increase of $715,610, or approximately 108.62%. The increase was primarily attributable to expanded 5G product development activities, including higher prototype and testing costs, as well as increased consulting expenses to support ongoing product innovation and development efforts.

 

Loss From Operations

 

As a result of the above, the Company reported a loss from operations of $3,195,920 and $1,925,059 for the three months ended June 30, 2026, and 2025, respectively.

 

Other Income (Expenses)

 

Other income consists of $88,222 of realized gain on foreign currency exchange rates for the three months ended June 30, 2025.

 

Due to market fluctuations, the Company recorded an unrealized loss on investments of $13,363 for the three months ended June 30, 2026 and $62,499 and $36,019 of realized gains on investments for the three months ended June 30, 2026 and 2025, respectively.

 

The Company recorded interest income, net of $58,272 and $29,193 for the three months ended June 30, 2026 and 2025, respectively.

 

Net Loss

 

The Company reported a net loss of $3,088,512 and $1,771,625 for the three months ended June 30, 2026 and 2025, respectively.

 

25

 

 

For the Six Months Ended June 30, 2026 and June 30, 2025

 

Revenues

 

Sales decreased to $13,419,825 for the six months ended June 30, 2026, from $14,625,026 for the six months ended June 30, 2025, a decrease of $1,205,201, or approximately 8.24%. The decrease was primarily attributable to lower 5G product sales, as the same period in the prior year included revenue generated from the Titan asset acquisition, which contributed to incremental sales that did not recur in the current period, offset by the increase in Spectrum sales.

 

Cost of Goods Sold and Gross Profit

 

Cost of goods sold decreased to $8,598,947 for the six months ended June 30, 2026, from $12,574,277 for the six months ended June 30, 2025, a decrease of $3,975,330, or approximately 31.61%. The decrease was primarily attributable to lower sales volumes. The same period in the prior year included the fulfillment of acquired 5G product sales resulting from the asset acquisition, which increased both sales and the related cost of goods sold. Gross profit increased to $4,820,878 for the six months ended June 30, 2026, from $2,050,749 for the six months ended June 30, 2025, an increase of $2,770,129, or approximately 135.08%. Gross profit as a percentage of sales increased to approximately 35.92% for the six months ended June 30, 2026, from approximately 14.02% for the comparable same period in the prior year. The improvement in gross margin was primarily attributable to a more favorable product mix and the absence of the lower-margin acquired 5G product sales that were included in the same period in the prior year.

 

Selling, General and Administrative Expenses

 

Selling, general and administrative expenses increased to $7,758,455 for the six months ended June 30, 2026, from $4,467,358 for the six months ended June 30, 2025, an increase of $3,291,097, or approximately 73.67%. The increase was primarily attributable to higher parent company expenses, including increased amortization expense, legal fees and stock-based compensation. Selling, general and administrative expenses also increased due to greater investments in marketing and business development activities, including participation in additional industry trade shows such as IMS, MWC and Network X trade shows, expanded promotional initiatives to enhance brand awareness and customer engagement, and the engagement of two consultants to support the marketing and business development of the Company’s 5G product portfolio.

 

Research and Development Expenses

 

Research and development expenditures are charged to operations as incurred. The major components of research and development costs include salaries and benefits, consultants, outside service, and supplies.

 

Research and development costs for the six months ended June 30, 2026, and 2025, were $1,877,451 and $1,398,468, respectively, an increase of $478,983, or 34.25%. The increase was primarily attributable to continued investment in 5G product development, including higher prototype and testing costs and increased consulting expenses to support ongoing research, product innovation, and development activities.

 

Loss From Operations

 

As a result of the above, the Company reported a loss from operations of $4,815,028 and $3,815,077 for the six months ended June 30, 2026, and 2025, respectively.

 

26

 

 

Other Income (Expenses)

 

Other income consists of $88,222 of realized gain on foreign currency exchange rates for the six months ended June 30, 2025.

 

Due to market fluctuations, the Company recorded an unrealized gain on investments of $24,601 for the six months ended June 30, 2026 and $62,499 and $36,019 of realized gains on investments for the six months ended June 30, 2026 and 2025, respectively.

 

The Company recorded interest income, net of $117,709 and $78,690 for the six months ended June 30, 2026 and 2025, respectively.

 

Net Loss

 

The Company reported a net loss of $4,610,219 and $3,612,146 for the six months ended June 30, 2026 and 2025, respectively.

 

Cash Flow

 

Operating Activities

 

The net cash used in operating activities for the six months ended June 30, 2026, was $8,678,386 resulting primarily from the net loss and operating changes in accounts receivable, inventory, prepaid expenses, long-term deposits, accounts payable and accrued expenses and operating lease obligations and customer deposits.

 

The net cash used in operating activities for the six months ended June 30, 2025, was $4,260,237 resulting primarily from the net loss and operating changes in accounts receivable, inventory, prepaid expenses, long-term deposits, accounts payable and accrued expenses and operating lease obligations and customer deposits.

 

Investing Activities

 

The net cash used in investing activities for the six months ended June 30, 2026, was $4,530,283 representing the net investment in marketable securities and the purchase of property and equipment.

 

The net cash used in investing activities for the six months ended June 30, 2025, was $3,987,492 for the purchase of property and equipment and the Titan Asset Acquisition.

 

Financing Activities

 

The net cash provided by financing activities for the six months ended June 30, 2026, was $10,529,115 resulting primarily from the net proceeds received from the rights offering, the registered direct offering and proceeds received from the exercise of stock options.

 

The net cash used in financing activities for the six months ended June 30, 2025, was $10,500 resulting primarily from the repayments of financing lease obligations.

 

As of June 30, 2026, we had cash and cash equivalents of $8,892,838, rights offering subscription proceeds in escrow of $113,003, working capital of $22,932,180 and an accumulated deficit of $32,629,501.

 

As of December 31, 2025, we had cash and cash equivalents of $4,981,091, rights offering subscription proceeds in escrow of $6,704,304, working capital of $10,157,641 and an accumulated deficit of $28,019,282.

 

Operating Capital and Capital Expenditure Requirements

 

As of June 30, 2026, we had cash and cash equivalents of $8,892,838. Based on our existing cash and cash equivalents, our working capital, our current and forecasted level of operations, and our forecasted cash flows, we believe that we will be able to meet our obligations and pay our liabilities arising from normal business operations when they come due and to provide for our capital requirements for the next 12 months.

 

27

 

 

Critical Accounting Policies, Estimates and Assumptions

 

The SEC defines critical accounting policies as those that are, in management’s view, most important to the portrayal of our financial condition and results of operations and those that require significant judgment and estimates.

 

The discussion and analysis of our financial condition and results of operations is based upon financial statements which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets and liabilities. On an on-going basis, we evaluate our estimates, including the allowance for doubtful accounts, the salability and recoverability of inventory, income taxes and contingencies. We base our estimates on historical experience and on other assumptions that we believe to be reasonable under the circumstances, the results of which form our basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. The Company believes there have been no significant changes during the three month period ended June 30, 2026, to the items disclosed as critical accounting policies in management’s discussion and analysis in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025.

 

We cannot predict what future laws and regulations might be passed that could have a material effect on our results of operations. We assess the impact of significant changes in laws and regulations on a regular basis and update the assumptions and estimates used to prepare our financial statements when we deem it necessary.

 

Off Balance Sheet Transactions

 

None.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

 

Smaller reporting companies are not required to provide the information required by this item.

 

Item 4. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures

 

Under the supervision and with the participation of management, including our chief executive officer and chief financial officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of June 30, 2026, as such term is defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act. As a result of this evaluation, our chief executive officer and chief financial officer have concluded that, as of June 30, 2026, our disclosure controls and procedures were not effective due to the material weaknesses in internal control over financial reporting described below. Notwithstanding the identified material weaknesses, management, including our chief executive officer and chief financial officer, believes the condensed consolidated financial statements included in this report fairly represent, in all material respects, our financial condition, results of operations and cash flows as of and for the periods presented in accordance with GAAP.

 

Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure. Our management does not expect that our disclosure controls and procedures will prevent all error and all fraud. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.

 

Management’s Report on Internal Control over Financial Reporting

 

Management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act. Management has evaluated the effectiveness of our internal control over financial reporting based on criteria established in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. As a result of this evaluation, management has concluded that, as of June 30, 2026 our internal control over financial reporting was not effective due to the material weaknesses in internal control over financial reporting due to previously identified material weaknesses resulting from lack of written documentation of our internal controls and procedures, having ineffective internal controls related to our information technology general controls and lack of personnel resources to ensure adequate segregation of duties, as disclosed in the Form 10-K for the fiscal year ended December 31, 2025 (“Form 10-K”).

 

We continue to focus on our remediation plan disclosed in our Form 10-K.

 

In addition, we will continue to enhance corporate oversight over process-level controls and structures to ensure that there is appropriate assignment of authority, responsibility, and accountability to enable remediation of our material weaknesses. We believe that our remediation plan will be sufficient to remediate the identified material weaknesses and strengthen our internal control over financial reporting. As we continue to evaluate, and work to improve, our internal control over financial reporting, management may determine that additional measures to address control deficiencies or modifications to the remediation plan are necessary.

 

Changes in Internal Control over Financial Reporting

 

Except for the foregoing, there were no changes that have affected, or are reasonably likely to materially affect, our internal control over financial reporting (as defined in Rules 13a-15(f) or 15d-15(f) under the Exchange Act) during the period covered by this report.

 

28

 

 

PART II — OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

To the best of our knowledge, there are no pending legal proceedings to which we are a party or of which any of our property is the subject.

 

Item 1A. Risk Factors.

 

Carefully consider the risks set forth in the section captioned “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 before making an investment decision. You should read the section captioned “Cautionary Statement Regarding Forward Looking Statements” above for a discussion of what types of statements are forward-looking statements, as well as the significance of such statements in the context of this report.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

On April 2026, we issued an aggregate of 7,510 shares of our common stock to a board advisor for his services.

 

On June 9, 2026, we entered into a consulting agreement pursuant to which we agreed to issue an aggregate of 800,002 shares of common stock in installments as compensation for services pursuant to and subject to the terms of the consulting agreement. The initial 100,000 shares of common stock were issued in June 2026, and the remaining balance of 700,002 shares of common stock will be issued in monthly installments of 77,778 commencing in October 2026 for continued services.

 

The offers, sales, and issuances of the securities described above were deemed to be exempt from registration under the Securities Act in reliance on Section 4(a)(2) of the Securities Act or Rule 506 of Regulation D promulgated thereunder as transactions by an issuer not involving a public offering.

 

Item 3. Defaults Upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

Not applicable

 

Item 5. Other Information.

 

None

 

Item 6. Exhibits.

 

(a) Exhibits

 

Exhibit No.   Description
31.1*   Rule 13a-14(a)/ 15d-14(a) Certification of Principal Executive Officer
31.2*   Rule 13a-14(a)/ 15d-14(a) Certification of Principal Financial Officer
32.1*   Section 1350 Certification of Principal Executive Officer
32.2*   Section 1350 Certification of Principal Financial Officer
101. INS   XBRL Instance Document
101. SCH   XBRL Taxonomy Extension Schema Document
101. CAL   XBRL Taxonomy Extension Calculation Link base Document
101. DEF   XBRL Taxonomy Extension Definition Link base Document
101. LAB   XBRL Taxonomy Extension Label Link base Document
101. PRE   XBRL Taxonomy Extension Presentation Link base Document

 

* Furnished herewith

 

29

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  AmpliTech Group, Inc.
     
Date: August 13, 2026 By: /s/ Fawad Maqbool
    Fawad Maqbool
    President and Chief Executive Officer
    (Principal Executive Officer)

 

Date: August 13, 2026 By: /s/ Louisa Sanfratello
    Louisa Sanfratello
    Chief Financial Officer
    (Principal Financial and Accounting Officer)

 

30